Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
about
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanCost-effectiveness of managing HIV infection.The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population-based study in rural South Africa.Clustering based on adherence data.Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcareOutcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History StudyPoverty, hunger, education, and residential status impact survival in HIV.Severity of outcomes associated to illnesses funded by GFATM initiative and socio demographic and economic factors associated with HIV/AIDS, TB and malaria mortality in Kinshasa Hospitals, DRC.Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.Unemployment, public-sector health care expenditure and HIV mortality: An analysis of 74 countries, 1981-2009Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.Rates of inappropriate antiretroviral prescription among injection drug users.Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort.Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.Epidemiology of HIV/AIDS in the East Azerbaijan Province, Northwest of Iran.Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature.Sociodemographic characteristics explain differences in unprotected sexual behavior among young HIV-negative gay, bisexual, and other YMSM in New York City.Rural AIDS diagnoses in Florida: changing demographics and factors associated with survival.Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe.Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.Socioeconomic Status and Survival of People with Human Immunodeficiency Virus Infection before and after the Introduction of Highly Active Antiretroviral Therapy: A Systematic Literature Review.AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil.Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada.Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City.Unemployment and HIV mortality in the countries of the Organisation for Economic Co-operation and Development: 1981-2009.Are neighborhood conditions associated with HIV management?The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints.Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways.Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand.Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations.A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.Use of antiretroviral therapy among HIV positive individuals living in British ColumbiaCommunity poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004
P2860
Q28749991-746CBB56-AC7B-43A7-9974-FCD024EF78AAQ30381397-DDCFF5B5-11E6-4081-8C12-0B25CE489567Q33760307-0D9EF2BD-4E9D-43D1-813F-21526FF66205Q33840321-B2542E46-BAFB-46D4-B8E2-AE07833621B7Q33863309-10A63162-81C3-4720-A12F-2F6104BCCB48Q33951598-436A719A-B894-4DD1-A4CC-0B38B57935DAQ34441490-27169912-2A21-431D-9F17-865D59FD45ADQ34588953-E99B5C5C-6DCB-4027-B331-1094C790431DQ34795325-EDA88D13-696F-44D4-9ED1-D059E5DBA0CBQ35109834-D94654FE-14D6-4CF7-9BCC-E36D71EEDCC1Q35119311-17575D22-601A-4457-8DDE-C605B9B7E7C8Q35585411-AC05CC2D-1D10-4E63-82C4-1A6A4B4C1043Q35647138-5CB030FF-482A-4F7D-965E-FEB222444352Q36112621-D13DEE7C-FA84-49AC-B3D2-9B3A264EA1EDQ36147419-4EB967EA-EA34-4F01-810E-6D65D56316A2Q36495523-48DEC5C3-D385-4F1F-A6AC-77B7B7067B13Q36679678-D2D641A0-37EF-4D26-A20B-6B48D449E69FQ36962851-3C1B1D20-0FE9-4942-A518-6501DCAD2F71Q37121216-46DDCA41-2F0C-4900-886B-E0FBCFF08B77Q37550334-C6432115-DCB3-44D3-AF76-85865C0F4E2EQ37600454-AC174C83-04B7-4BC1-B286-BEBC8A60B260Q38444931-628F88F8-D125-4931-AA38-AA4A8EB107AFQ38670050-CD6A3532-48D7-46DB-8C4B-7D5C06D2F5AEQ38979755-1E0E5095-E9E6-4A58-A45C-6231499CB5DBQ40106758-555697D7-D4D8-41D7-8D22-E6E49C81A1CFQ40127035-0808DF43-BA15-4DF1-A341-29A54DF595B6Q46097976-76635764-F4ED-4B9B-8320-7ACE9A3A8DC7Q46943291-B1A12F6B-0477-46AC-B700-8F5D7B26F6EBQ50132784-8EF654ED-4921-494D-B83C-96D58F06908AQ51783141-5161B76E-44F0-4E5C-A508-CAC2F08254DEQ53438171-FE1C92EC-F139-494E-AA64-5F715C0C958CQ57259749-A2FAE3FA-79B7-4D4B-BF05-3E9BF67B6F9AQ58856106-68090A94-A880-4002-BD0B-D08164818F33
P2860
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@en
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@nl
type
label
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@en
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@nl
prefLabel
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@en
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@nl
P2093
P50
P1433
P1476
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
@en
P2093
David Bangsberg
Keith Chan
Michael V O'Shaughnessy
P304
P356
10.1097/00002030-200210180-00012
P407
P577
2002-10-01T00:00:00Z